Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.4M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
47.6M
-
Shares change
-
-619K
-
Total reported value, excl. options
-
$1.71B
-
Value change
-
-$17.2M
-
Put/Call ratio
-
0.23
-
Number of buys
-
72
-
Number of sells
-
-56
-
Price
-
$35.88
Significant Holders of Arcellx, Inc. - COMMON STOCK (ACLX) as of Q3 2023
155 filings reported holding ACLX - Arcellx, Inc. - COMMON STOCK as of Q3 2023.
Arcellx, Inc. - COMMON STOCK (ACLX) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.6M shares
of 55.4M outstanding shares and own 85.88% of the company stock.
Largest 10 shareholders include FMR LLC (4.54M shares), PERCEPTIVE ADVISORS LLC (3.97M shares), SR ONE CAPITAL MANAGEMENT, LP (3.95M shares), NEA Management Company, LLC (3.75M shares), Paradigm Biocapital Advisors LP (2.95M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.87M shares), BlackRock Inc. (2.71M shares), Cormorant Asset Management, LP (2.15M shares), VANGUARD GROUP INC (2.04M shares), and STATE STREET CORP (2.01M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.